Almac Clinical Services, a subsidiary of Almac Group, has introduced its Tempod 1000 that is claimed to enhance the company's Site Compliance and temperature management offering for sponsors, it was reported on Wednesday.
Intended to augment Almac's established temperature management service, Tempod 1000 is a USB device that captures and stores all clinical site temperature data and automatically finds unreported excursions once uploaded into TempEZ. It is aimed at removing the administrative burden of updating manual temperature logs, increasing site compliance with reporting data and promoting best digital practice in clinical studies and patient safety.
The device will also decrease the risk of missed patient visits due to unreported excursions, enable sponsors and CRAs to identify and resolve excursions remotely, accelerates CRA review time during site visits, and facilitate timely and efficient study close-outs and database locks.
OSR Holdings to acquire Korean non-invasive glucose monitor developer Woori IO
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
GSK commits USD30bn to US R&D and manufacturing expansion
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch
Elute partners Spartan Medical
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD